(calpain inhibitor) Study identifies potential combination therapy for ovarian cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, October 29, 2016

(calpain inhibitor) Study identifies potential combination therapy for ovarian cancer



medical news

In a comparative analysis, the authors previously described the similarities in the genetic and epigenetic events of breast and ovarian cancer suggesting a common epigenetic origin. They have shown before that combination of histone deacetylase inhibitors with calpain inhibitor produced enhanced growth inhibition and cell death in different types of breast cancer cells including triple negative as they observed in different types of cells in this study.

0 comments :

Post a Comment

Your comments?